BindingDB logo
myBDB logout

BDBM50059366 ((S)-2-{(S)-2-[2-((S)-2-{(R)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-propionylamino}-3-phenyl-propionylamino)-2-methyl-propionylamino]-3-methyl-butyrylamino}-3-methyl-butyrylamino)-acetic acid::CHEMBL86765

SMILES: CC(C)[C@H](NC(=O)[C@@H](NC(=O)C(C)(C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(O)=O

InChI Key: InChIKey=JIFGFHCNSVBRAC-OBWLXNIXSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50059366   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Opioid receptors; mu & delta


(Rattus norvegicus (rat))
BDBM50059366
PNG
(((S)-2-{(S)-2-[2-((S)-2-{(R)-2-[(S)-2-Amino-3-(4-h...)
Show SMILES CC(C)[C@H](NC(=O)[C@@H](NC(=O)C(C)(C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(O)=O
Show InChI InChI=1S/C37H53N7O9/c1-20(2)29(34(51)39-19-28(46)47)42-35(52)30(21(3)4)43-36(53)37(6,7)44-33(50)27(18-23-11-9-8-10-12-23)41-31(48)22(5)40-32(49)26(38)17-24-13-15-25(45)16-14-24/h8-16,20-22,26-27,29-30,45H,17-19,38H2,1-7H3,(H,39,51)(H,40,49)(H,41,48)(H,42,52)(H,43,53)(H,44,50)(H,46,47)/t22-,26+,27+,29+,30+/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
0.110n/an/an/an/an/an/an/an/a



National Institute of Environmental Health Sciences

Curated by ChEMBL


Assay Description
Affinity of the compound was assessed using competitive binding assay labeled with [3H]-DPDPE (6.3 nM) for Opioid receptor delta 1


J Med Chem 40: 2579-87 (1997)


Article DOI: 10.1021/jm9700530
BindingDB Entry DOI: 10.7270/Q25M64T2
More data for this
Ligand-Target Pair
Mu-type opioid receptor


(Rattus norvegicus (rat))
BDBM50059366
PNG
(((S)-2-{(S)-2-[2-((S)-2-{(R)-2-[(S)-2-Amino-3-(4-h...)
Show SMILES CC(C)[C@H](NC(=O)[C@@H](NC(=O)C(C)(C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(=O)NCC(O)=O
Show InChI InChI=1S/C37H53N7O9/c1-20(2)29(34(51)39-19-28(46)47)42-35(52)30(21(3)4)43-36(53)37(6,7)44-33(50)27(18-23-11-9-8-10-12-23)41-31(48)22(5)40-32(49)26(38)17-24-13-15-25(45)16-14-24/h8-16,20-22,26-27,29-30,45H,17-19,38H2,1-7H3,(H,39,51)(H,40,49)(H,41,48)(H,42,52)(H,43,53)(H,44,50)(H,46,47)/t22-,26+,27+,29+,30+/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
4.48n/an/an/an/an/an/an/an/a



National Institute of Environmental Health Sciences

Curated by ChEMBL


Assay Description
Affinity of the compound was assessed using competitive binding assay labeled with [3H]- DAGO (1.28 nM) for Opioid receptor mu 1


J Med Chem 40: 2579-87 (1997)


Article DOI: 10.1021/jm9700530
BindingDB Entry DOI: 10.7270/Q25M64T2
More data for this
Ligand-Target Pair